8-K: National Health Investors Secures Amended $700 Million Credit Facility and Aligns Term Loan

National Health Investors has entered into an amended and restated credit agreement providing a $700 million revolving credit facility and aligned its existing term loan agreement with the new credit terms.

Summary

• National Health Investors (NHI) has finalized an amended and restated credit agreement on October 24, 2024, securing a $700 million revolving credit facility.
• This new agreement replaces the existing credit agreement from March 31, 2022, and includes an option to increase the total facility to $1 billion.
• The revolving credit facility matures on October 24, 2028, with options for extensions of up to 12 months, subject to fees.
• NHI also has access to letters of credit and swingline loans, each up to $30 million.
• As of October 24, 2024, $307.4 million was outstanding under the new revolving credit facility.
• The interest rates on borrowings are variable, based on Term SOFR, Daily SOFR, or a base rate, plus a margin dependent on NHI's credit rating.
• The agreement includes financial covenants such as a maximum debt-to-asset ratio of 0.60 to 1.00 (or 0.65 to 1.00 after material acquisitions), a minimum net worth of $1.475 billion, and a minimum EBITDA to fixed charges ratio of 1.50 to 1.00.
• NHI also amended its existing $200 million term loan agreement to align its terms with the new credit agreement.
• The term loan matures on June 16, 2025, and has an outstanding balance of $200 million as of October 24, 2024.

Sentiment

Score: 7

Explanation: The document indicates a positive step in securing financing, but also highlights the debt obligations and financial covenants. The sentiment is moderately positive as it is a routine financial transaction.

Positives

• The new credit facility provides NHI with a substantial $700 million in revolving credit, with the potential to increase to $1 billion.
• The extension options on the revolving credit facility provide flexibility in managing debt maturity.
• The alignment of the term loan agreement with the new credit facility simplifies financial management.
• The inclusion of letters of credit and swingline loan options enhances NHI's financial flexibility.

Negatives

• The credit agreement includes financial covenants that NHI must adhere to, which could restrict operational flexibility.
• The company is subject to variable interest rates on borrowings, which could increase costs if rates rise.
• The company has $307.4 million outstanding under the new revolving credit facility, which is a significant debt obligation.

Risks

• Failure to comply with financial covenants could trigger an event of default, potentially leading to acceleration of debt payments.
• Fluctuations in interest rates could increase the cost of borrowing under the revolving credit facility.
• The company's credit rating will impact the interest rate margin and facility fees, which could increase costs if the rating is downgraded.
• The company has a significant amount of debt outstanding, which could impact its financial stability.

Future Outlook

The company has secured a new credit facility and aligned its term loan, providing financial flexibility for future operations and potential growth. The company has the option to extend the revolving credit facility and increase the total facility size.

Management Comments

• The company has entered into an Amended and Restated Credit Agreement with Wells Fargo Bank, National Association, as administrative agent.
• The company has also entered into an Amendment No. 1 to Term Loan Agreement with Wells Fargo Bank, National Association, as administrative agent.

Industry Context

This announcement is typical for REITs (Real Estate Investment Trusts) like NHI, which often use credit facilities to fund acquisitions and operations. Securing favorable credit terms is crucial for maintaining financial stability and growth in the healthcare real estate sector.

Comparison to Industry Standards

• The credit facility size of $700 million is substantial and in line with other mid-sized healthcare REITs.
• The financial covenants, such as the debt-to-asset ratio and EBITDA to fixed charges ratio, are standard for the industry.
• Companies like Ventas (VTR) and Welltower (WELL) also utilize revolving credit facilities and term loans for their financing needs, with similar terms and conditions.
• The interest rate margins are dependent on the company's credit rating, which is a common practice in the industry.

Related Party Transactions

• Certain lenders under the Revolving Credit Facility and the Term Loan or their affiliates have provided, and may in the future provide, certain commercial banking, financial advisory, and investment banking services in the ordinary course of business for the Company, its subsidiaries and certain of its affiliates, for which they receive customary fees and commissions.

Stakeholder Impact

• Shareholders will be impacted by the company's ability to manage its debt and comply with financial covenants.
• Creditors are impacted by the terms of the new credit facility and the company's ability to repay its obligations.
• Employees are indirectly impacted by the company's financial stability and ability to operate effectively.

Next Steps

• The company will file copies of the Credit Agreement and the Amendment as exhibits to its Annual Report on Form 10-K for the year ending December 31, 2024.

Key Dates

Keywords

credit facility, revolving loan, term loan, debt, financial covenants, interest rates, National Health Investors, NHI, Wells Fargo